developed a polypeptide‐based nanocarrier to co‐deliver DOX and the diABZI STING agonist 3 (dSA3),[52e] achieving APC‐specific delivery and tumor phagocytosis‐driven STING pathway activation. The gene discussed is STING1; the disease is neoplasm.